It has been reported that FGFR3 has a common mutational gene in bladder cancer and its mutation was associated with a favorable BC prognosis, which was in accordance with the low UPR-related risk score in the mutational type of EGFR3. The gene discussed is FGFR3; the disease is breast cancer.